Advertisement
UK markets closed
  • FTSE 100

    7,682.50
    +52.48 (+0.69%)
     
  • FTSE 250

    19,354.38
    +299.51 (+1.57%)
     
  • AIM

    741.31
    +4.81 (+0.65%)
     
  • GBP/EUR

    1.1668
    -0.0013 (-0.11%)
     
  • GBP/USD

    1.2655
    +0.0029 (+0.23%)
     
  • Bitcoin GBP

    48,673.04
    -318.37 (-0.65%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,137.08
    +40.81 (+0.80%)
     
  • DOW

    39,087.38
    +90.99 (+0.23%)
     
  • CRUDE OIL

    79.81
    +1.55 (+1.98%)
     
  • GOLD FUTURES

    2,091.60
    +36.90 (+1.80%)
     
  • NIKKEI 225

    39,910.82
    +744.63 (+1.90%)
     
  • HANG SENG

    16,589.44
    +78.00 (+0.47%)
     
  • DAX

    17,735.07
    +56.88 (+0.32%)
     
  • CAC 40

    7,934.17
    +6.74 (+0.09%)
     

ICP Monitoring Devices Pipeline by Stages of Development, Segments, Region, Regulatory Pathways and Key Companies, 2023 and Beyond

Company Logo
Company Logo

Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "ICP Monitoring Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies" report has been added to ResearchAndMarkets.com's offering.

This report provides comprehensive information about the ICP Monitoring Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. External Ventricular Drainage (EVD) and Microtransducer Devices are covered under this segment. One unit refers to one ICP Monitoring Device.

Report Scope

  • Extensive coverage of the ICP Monitoring Devices under development

  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

  • The report reviews the major players involved in the development of ICP Monitoring Devices and list all their pipeline projects

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment/industry

The report will enable you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

  • Identify and understand important and diverse types of ICP Monitoring Devices under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 ICP Monitoring Devices Overview

3 Products under Development
3.1 ICP Monitoring Devices - Pipeline Products by Stage of Development
3.2 ICP Monitoring Devices - Pipeline Products by Segment
3.3 ICP Monitoring Devices - Pipeline Products by Territory
3.4 ICP Monitoring Devices - Pipeline Products by Regulatory Path
3.5 ICP Monitoring Devices - Pipeline Products by Estimated Approval Date
3.6 ICP Monitoring Devices - Ongoing Clinical Trials

4 ICP Monitoring Devices - Pipeline Products under Development by Companies
4.1 ICP Monitoring Devices Companies - Pipeline Products by Stage of Development
4.2 ICP Monitoring Devices - Pipeline Products by Stage of Development

5 ICP Monitoring Devices Companies and Product Overview

6 ICP Monitoring Devices- Recent Developments
6.1 Nov 11, 2022: Hosiden announces Financial Results for the six months ended September.30,2022
6.2 Oct 06, 2022: Integra LifeSciences appoints Harvinder Singh as Executive Vice President, President of Co.'s International Business
6.3 Oct 06, 2022: Integra LifeSciences Announces Key Executive Appointment

A selection of companies mentioned in this report includes:

  • Ad-Tech Medical Instrument Corp

  • Boston Neurosciences

  • Brain4Care Inc

  • City, University of London

  • Columbia University

  • CranioSense LLC

  • Drexel University

  • Duke University

  • HeadSense Medical Ltd.

  • Integrated Sensing Systems Inc

  • Irras AB

  • Johns Hopkins University

  • Koronis Biomedical Technologies Corporation

  • Neurallys

  • NeuroDx Development, LLC

  • Northwestern University

  • NovaSignal Corp

  • Orsan Medical Technologies Ltd.

  • P2D Inc

  • Qura Inc

  • Remote Vital Monitoring Inc

  • Rytek Medical Inc

  • Spiegelberg GmbH & Co KG

  • Stanford University

  • The Feinstein Institute for Medical Research

  • Third Eye Diagnostics Inc

  • University of Illinois

  • Virginia Commonwealth University

  • Washington University in St Louis

  • Wisconsin Institute of Nuclear Systems

For more information about this report visit https://www.researchandmarkets.com/r/y6vj7r

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900